Advertisement
Screener

Q/C Technologies, Inc. (QCLS) Adjustments to Additional Paid in Capital, Other

1.2 / 5 stars · 16/66 Roast Me

Q/C Technologies, Inc. Adjustments to Additional Paid in Capital, Other

Q/C Technologies, Inc. (QCLS) reported Adjustments to Additional Paid in Capital, Other of $19.31 million for the 3-month period ending 2024-09-30, per its 10-Q filed 2024-11-14.

Financial Statements › Shareholders' Equity

us-gaap:AdjustmentsToAdditionalPaidInCapitalOther · last filed 2024-11-14

  • Q/C Technologies, Inc. adjustments to additional paid in capital, other for the quarter ending 2024-09-30 was $19.31M.
  • Q/C Technologies, Inc. adjustments to additional paid in capital, other for the quarter ending 2024-03-31 was $7.96M.
Period endAdjustments to Additional Paid in Capital, Other 0 monthAdjustments to Additional Paid in Capital, Other 3 month
2024-09-30$19.31M
10-Q · filed 2024-11-14
2024-03-31$7.96M
10-Q · filed 2024-11-14
2015-04-08$64.09K
10-K · filed 2017-04-11
2015-03-09$64.67K
10-K · filed 2017-04-11

Similar stocks

Stock NameCountryMarket CapPE Ratio
Cardio Diagnostics Holdings, Inc. (CDIO)United States$0.006B
BIOMERICA INC (BMRA)United States$0.011B
VOLITIONRX LTD (VNRX)$0.003B-0.64
IMMUCELL CORP /DE/ (ICCC)United States$0.091B116.10
Insight Molecular Diagnostics Inc. (IMDX)United States$0.129B-3.90
MYRIAD GENETICS INC (MYGN)United States$0.397B-4.84
Alpha Teknova, Inc. (TKNO)United States$0.500B-18.12
QuidelOrtho Corp (QDEL)United States$0.733B-0.90
ACHIEVE LIFE SCIENCES, INC. (ACHV)United States$0.806B-5.88
Intellia Therapeutics, Inc. (NTLA)United States$1.705B-5.92